Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 177

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 177
---
<div align='center'>110</div>

Compensation of Directors

The following table sets forth the components
of compensation for each non-employee director that served as a director during the year ended December 31, 2024:

Year Ended December 31, 2024

| Name               |     | Fees earned 
 or paid in  
 cash        
 $           |        |     | Stock  
 awards 
 $      |    |     | Option     
 awards (1) 
 $          |         |     | Non-Equity     
 Incentive Plan 
 Compensation   
 $              |    |     | Non-Qualified 
 deferred      
 compensation  
 $             |    |     | all other    
 compensation 
 $            |        |     | Total 
 $     |         |
| Bernard Bertal (2) |     |             | 10,000 |     |        | -- |     |            | 172,000 |     |                | -- |     |               | -- |     |              | 57,000 |     |       | 239,000 |
| Mordechai Munk     |     |             | 10,000 |     |        | -- |     |            |      -- |     |                | -- |     |               | -- |     |              |     -- |     |       |  10,000 |
| Moti Jacobson (3)  |     |             | 10,000 |     |        | -- |     |            |      -- |     |                | -- |     |               | -- |     |              |     -- |     |       |  10,000 |
| Eyal Flom (4)      |     |             | 10,000 |     |        | -- |     |            |      -- |     |                | -- |     |               | -- |     |              |     -- |     |       |  10,000 |

| (1) | In accordance with SEC                                                                                                                     
 rules, the amounts in this column reflect the fair value on the grant date of the option awards granted to the named executive, calculated 
 in accordance with ASC Topic 718. Stock options were valued using the Black-Scholes model. The grant-date fair value does not necessarily  
 reflect the value of shares which may be received in the future with respect to these awards. The grant-date fair value of the stock       
 options in this column is a non-cash expense for us that reflects the fair